NHF’s Next Collaborative Learning Exchange will be on
VWD Treatment Across the Lifespan for Women, Girls, and People with the Propensity to Menstruate (WGPPM)
This virtual activity will be held live on April 13, 2023, from 2:00 pm - 3:00 pm EDT / 1:00 pm - 2:00 pm CDT/ 12:00 pm - 1:00 pm MDT/ 11:00 am - 12:00 pm PDT.
This live, virtual training will provide prescribers with an opportunity for interactive discussion about the evolving treatment needs of Women, Girls, and People with the Propensity to Menstruate (WGPPM) across their lifespan, including management of heavy menstrual bleeding and perioperative care for both cis gender and transgender patients who were assigned female at birth.
Participants will be asked to apply their own decision-making skills in considering several case studies.
These activities are intended for physicians, physician assistants, and nurse practitioners who regularly prescribe therapies for individuals living with von Willebrand disease and/or hemophilia A and B.
The event will be moderated by:
Manager of Medical Education Grants
National Hemophilia Foundation
The event presenters are:
Nathan Connell, MD, MPH, FACP
Associate Professor of Medicine at Harvard Medical School
Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital
Member of the active staff at the Dana-Farber Cancer Institute
Angela C. Weyand, MD
Clinical Associate Professor at the University of Michigan Health
Pediatric Hematology/Oncology at C. S. Mott Children’s Hospital
Co-Director of combined hematology/gynecology program serving Women and Girls
The event format will include:
- Presentation on the latest information on the evolving treatment needs of Women, Girls, and People with the Propensity to Menstruate (WGPPM) including the management of heavy menstrual bleeding and perioperative care for both cis gender and transgender patients who were assigned female at birth
- Group review and discussion of case studies
- Summary and discussion of lessons learned
- Characterize the evolution of treatment for VWD across the lifespan for Women, Girls, and People with the Propensity to Menstruate (WGPPM)
- Identify treatment options for WGPPM living with VWD including perioperative management for patients requiring surgery involving cardiovascular interventions
- Discuss gender affirming care in the context of VWD
- Collaborate within the healthcare team for shared patient-centered and population focused problem-solving for those experiencing bleeding disorders as derived from discussion-based treatment strategies and evidence-based practice
Following the event, a resource document will be shared to support the learning provided by the activity along with a list of supplemental resources.
ACCREDITED CONTINUING EDUCATION
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and National Hemophilia Foundation. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.
University of Nebraska Medical Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
These trainings are supported by a Cooperative Agreement [Number NU01DD000006], funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.